Clinical Trial Administration

Click here to view our administrative clinical timeline.

The Houston Methodist Neal Cancer Center Clinical Trials Organization provides centralized resources for the conduct of cancer-related clinical research within the Houston Methodist Hospital System. The purpose of the CTO is to provide an effective and efficient infrastructure to support HMNCC investigators in developing, conducting, analyzing and reporting all cancer clinical research studies at HMNCC. HMNCC leadership is focusing on reshaping the clinical research portfolio to emphasize the growth of the NCTN portion of the portfolio with increased participation by HMNCC community-based investigators, and improved database and staffing support for investigator-initiated, early phase, clinical trials.

Director and Managers
  • Ahmed Bayoumi, MD, Administrative Director
    responsible for HMNCC clinical trial’s strategic planning and directs the CTO’s administrative, clinical, financial, human resources, and regulatory compliance activities to support the HMNCC goals.
  • Anne McCombs, Community Research Supervisor
    Provides clinical coordination and data management at all six HMH Community Hospitals namely Houston Methodist West Hospital, Houston Methodist Sugar Land Hospital, Houston Methodist Willowbrook Hospital, Houston Methodist The Woodlands Hospital, Houston Methodist Baytown Hospital and Houston Methodist Clear Lake Hospital.
  • Johanna Salom, Manager, Research Operations
    Oversees CTO regulatory affairs and research operations. Responsibilities impact the management, planning, development, budget, and administrative activities of the HMNCC Cancer Clinical Trials. Assists with strategic planning for department missions and growth.
  • Dalisa Santiago, MBA, BS, BSN, RN
    Oversees clinical trials coordination and data management at Houston Methodist Hospital. Additionally, Dalisa manages the clinical trials lab processing and shipping and treatment plans builds.

    If you have specific questions about clinical trials please contact us